Appian (APPN) reported $202.87 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 21.7%. EPS of $0.15 for the same period compares to $0 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $189.1 million, representing a surprise of +7.28%. The company delivered an EPS surprise of +59.57%, with the consensus EPS estimate being $0.09.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stree ...

Wall Street analysts expect Nvidia (NVDA) to post quarterly earnings of $1.52 per share in its upcoming report, which indicates a year-over-year increase of 70.8%. Revenues are expected to be $65.56 billion, up 66.7% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings release, it is of utmost importance ...

Nice (NICE) reported $786.5 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 9%. EPS of $3.24 for the same period compares to $3.02 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $778.66 million, representing a surprise of +1.01%. The company delivered an EPS surprise of +0.84%, with the consensus EPS estimate being $3.21.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...

In its upcoming report, Expeditors International (EXPD) is predicted by Wall Street analysts to post quarterly earnings of $1.46 per share, reflecting a decline of 13.1% compared to the same period last year. Revenues are forecasted to be $2.8 billion, representing a year-over-year decrease of 5.3%.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this ...

The upcoming report from Realty Income Corp. (O) is expected to reveal quarterly earnings of $1.08 per share, indicating an increase of 2.9% compared to the year-ago period. Analysts forecast revenues of $1.46 billion, representing an increase of 9.1% year over year.Over the last 30 days, there has been an upward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the co ...

Enpro (NPO) reported $295.4 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 14.3%. EPS of $1.99 for the same period compares to $1.57 a year ago.The reported revenue represents a surprise of +5.31% over the Zacks Consensus Estimate of $280.5 million. With the consensus EPS estimate being $1.91, the EPS surprise was +4.01%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine the ...

Core Insights - Halozyme Therapeutics reported a revenue of $451.77 million for the quarter ended December 2025, marking a 51.6% increase year-over-year, while EPS was -$0.24 compared to $1.26 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $448.62 million by 0.7%, but the EPS fell short of the consensus estimate of $2.15 by 111.16% [1] Revenue Breakdown - Product sales, net reached $122.67 million, surpassing the average estimate of $115.69 million by analysts, reflecting a year-over-year increase of 54.6% [4] - Royalties amounted to $257.97 million, slightly below the estimated $262.14 million, but still showing a 51.4% increase compared to the previous year [4] - Revenues from collaboration agreements were reported at $71.13 million, exceeding the average estimate of $61.31 million, representing a 47.5% year-over-year growth [4] Stock Performance - Over the past month, shares of Halozyme Therapeutics have returned +11.6%, contrasting with a -1.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Glaukos (GKOS) reported $143.12 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 35.7%. EPS of -$0.28 for the same period compares to -$0.40 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $142.93 million, representing a surprise of +0.13%. The company delivered an EPS surprise of -26.47%, with the consensus EPS estimate being -$0.22.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...

For the quarter ended December 2025, Itron (ITRI) reported revenue of $571.66 million, down 6.7% over the same period last year. EPS came in at $2.46, compared to $1.35 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $561.79 million, representing a surprise of +1.76%. The company delivered an EPS surprise of +12.55%, with the consensus EPS estimate being $2.19.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

With a market cap of $19.6 billion, Expeditors International of Washington, Inc. (EXPD) is a global logistics provider offering airfreight, ocean freight, customs brokerage, warehousing, and end-to-end supply chain solutions across the Americas, Europe, North Asia, South Asia, and MAIR. It serves industries such as retail, electronics, healthcare, technology, and manufacturing with specialized services including trade compliance, cargo insurance, and shipment monitoring. Shares of the Bellevue, Washingto ...